Investor Relations

To sign up to receive Investor News as it is released please email Walbrook PR

16/10/17	US Supply Agreement
10/10/17	Holding(s) in Company
05/09/17	Exercise of Options and Total Voting Rights
29/08/17	Result of AGM
18/07/17	Result of General Meeting
17/07/17	Result of Open Offer
06/07/17	Sale and leaseback of the building owned by Omega GmbH
30/06/17	Result of Proposed Fundraising
30/06/17	Proposed Fundraising
30/06/17	Final Results - FY17
25/04/17	Trading Update and Notice of Results
21/04/17	Holding(s) in Company
29/03/17	VISITECT® Malaria CE-Mark and successful Indian FDA inspection
07/03/17	Holding(s) in Company
27/02/17	Holding(s) in Company
22/01/17	Update on discussions with Immunodiagnostic Systems Holdings plc
11/01/17	ISO accreditation for manufacturing facility in Pune, India
24/11/16	Holding(s) in Company
17/10/16	Trading Update and Notice of Interim Results
10/08/16	Result of AGM
02/08/16	R&D Grant Funding
04/07/16	Holding(s) in Company
01/07/16	Holding(s) in Company
27/06/16	Final Results - FY16
09/06/16	Holding(s) in Company
21/04/16	Trading Update and Notice of Results
08/02/16	Holding(s) in Company
04/12/15	Holding(s) in Company
03/12/15	Holding(s) in Company
30/11/15	Half Yearly Report
26/10/15	Trading Update and Notice of Interim Results
30/09/15	Grant of Options
07/09/15	Result of Annual General Meeting
07/07/15	Final Results
05/06/15	Holding(s) in Company
01/06/15	Development Update - Visitect® CD4 and Allergy
27/04/15	Board Appointment
15/04/15	Trading update and Notice of Results
18/12/14	Director/PDMR Shareholding
01/12/14	Director/PDMR Shareholding
28/11/14	Director's Dealings
28/11/14	Director's Dealings
24/10/14	Trading Update and Notice of Interim Results